~~<i id='44748648A4'><strike id='44748648A4'><tt id='44748648A4'><pre id='44748648A4'></pre></tt></strike></i>~~

Home» comprehensive» Wikipedia

Wikipedia

author：leisure time 2025-09-30 19:31:41 Page View：26

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moderna says combo Covid
Next article： ChatGPT in medicine: STAT answers readers' burning questions

knowledge

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

'Essentially witchcraft:' A former naturopath takes on the field

ErosDervishiforSTATBrittHermesonceconsideredherselfadoctor.Now,she’sanapostate.Hermesspentthreeyears

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

After Sarepta trial failure, Duchenne families brace for more debate

KristofferTripplaar/SipaviaAPTohearSareptaCEODougIngramtellit,theresultsMondayafternoonfromalargetri

WSS

Wikipedia

Wikipedia

explore

knowledge

After Sarepta trial failure, Duchenne families brace for more debate